Inomata T - Search Results

1

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure　- Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study.

Kinugawa K, Sato N, Inomata T, Yasuda M, Shimakawa T, Fukuta Y. Kinugawa K, et al. Among authors: inomata t. Circ J. 2019 Jun 25;83(7):1520-1527. doi: 10.1253/circj.CJ-19-0158. Epub 2019 May 22. Circ J. 2019. PMID: 31118355 Free article.

2

[Heart failure].

Inomata T. Inomata T. Nihon Rinsho. 2001 Dec;59 Suppl 8:760-6. Nihon Rinsho. 2001. PMID: 11808305 Review. Japanese. No abstract available.

3

Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in Japan.

Inomata T, Izumi T, Kobayashi M. Inomata T, et al. Circ J. 2004 Jan;68(1):35-40. doi: 10.1253/circj.68.35. Circ J. 2004. PMID: 14695463 Free article.

4

Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure.

Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H, Shinagawa H, Takehana H, Izumi T. Koitabashi T, et al. Among authors: inomata t. Circ J. 2005 Jul;69(7):823-30. doi: 10.1253/circj.69.823. Circ J. 2005. PMID: 15988108 Free article.

5

Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure.

Niwano S, Fukaya H, Yuge M, Imaki R, Hirasawa S, Sasaki T, Yumoto Y, Inomata T, Izumi T. Niwano S, et al. Among authors: inomata t. Circ J. 2008 Feb;72(2):268-73. doi: 10.1253/circj.72.268. Circ J. 2008. PMID: 18219165 Free article.

6

Efficacy and safety of tolvaptan in heart failure patients with volume overload.

Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Kinugawa K, et al. Among authors: inomata t. Circ J. 2014;78(4):844-52. Epub 2014 Mar 21. Circ J. 2014. PMID: 24670835 Free article. Clinical Trial.

7

Parathyroid hormone in heart failure. Candidacy for a biomarker or therapeutic target?

Inomata T. Inomata T. Circ J. 2014;78(11):2631-2. doi: 10.1253/circj.cj-14-1077. Epub 2014 Oct 10. Circ J. 2014. PMID: 25311687 Free article. No abstract available.

8

Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study).

Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K, Mizuguchi K. Kinugawa K, et al. Among authors: inomata t. Int Heart J. 2015;56(2):137-43. doi: 10.1536/ihj.14-332. Epub 2015 Feb 23. Int Heart J. 2015. PMID: 25740389 Free article.

9

Errata: Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure.

Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K, Mizuguchi K. Kinugawa K, et al. Among authors: inomata t. Int Heart J. 2015;56(5):581. doi: 10.1536/ihj.56-5_Errata1. Epub 2015 Sep 4. Int Heart J. 2015. PMID: 26346521 Free article. No abstract available.

10

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　- A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Tsutsui H, Momomura S, Yamashina A, Ogawa H, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Ako J, Inomata T, Tanaka T, Kawasaki Y; study investigators. Tsutsui H, et al. Among authors: inomata t. Circ J. 2016;80(3):668-76. doi: 10.1253/circj.CJ-15-1112. Epub 2016 Jan 14. Circ J. 2016. PMID: 26763489 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters